PATENT CLAIM ANALYSIS

Application Number: 16007095
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Claim (Index 13):
The method of  claim 12 , wherein the particles have one or more of the following characteristics:\n (a) a mean bulk density (not tapped) between about 0.050 g/cm 3  and about 0.12 g/cm 3 ; (b) a SSA of at least 12 m 2 /g; (c) a SSA of between about 22 m 2 /g and about 40 m 2 /g; and/or (d) wherein at least 40% (w/w) of the paclitaxel is dissolved in 30 minutes or less in a solution of 50% methanol/50% water (v/v) at 37\u00b0 C. and pH 7.0 in a USP II paddle apparatus operating at 75 RPM.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15895197', '15174505', '13779625', '12436697', '15460552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6990079021221636
- 35 USC 102 Novelty (BERT): 0.521130247462841
- Combined Prediction Score: 0.6812201366562314
- Mean Citation Score: 270.84776600000004
- Max Citation Score: 316.4046600000001
- Similarity Product: 228.48806961342584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test